J&J makes bid to buy out remainder of Ci:z shares

Published: 24-Oct-2018
Finance

Beauty giant intends to strengthen presence in Japan with the acquisition

You need to be a subscriber to read this article.
Click here to find out more.

Johnson & Johnson (J&J) has announced it has launched an all-cash offer to acquire Japanese dermo cosmetic brand Ci:z in a bid to expand its consumer portfolio of science-based skin care brands.

The deal has been agreed by Ci:z Holdings and will affect all of Ci:z’s outstanding shares not already held by J&J and its affiliates for ¥5,900 per share, a total of approximately ¥230bn.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.

Subscribe now Already a subscriber? Sign in here.
  • Companies:
  • Johnson and Johnson
See more

You may also like

Skin Care

J&J to hold 9.5% stake in consumer health spinoff Kenvue following share exchange

Read more
The multinational launched the exchange offer in July in a bid to take its hands off the Kenvue reins

Trending Articles

  1. L’Oréal USA promotes Silvia Galfo to President of Luxe Division Galfo, previously Chief Growth Officer of the beauty group’s US subsidiary, will replace Megan Grant
  2. LVMH’s revenue dips despite ‘remarkable growth’ from Sephora The giant’s Selective Retailing and Perfumes & Cosmetics divisions delivered strong sales despite the ‘uncertain’ economic climate
  3. L'Occitane fends off lawsuit over online privacy violations Law firm Zimmerman Reed and 3,144 customers claimed that the company's website tracking tools violated consumer privacy
  4. Give Back Beauty lands Mercedes-Benz fragrance licence deal The group will now create, produce and distribute Mercedes-Benz fragrances after acquiring the automotive brand’s licence owner INCC Parfums
  5. Nivea helps push Beiersdorf sales to €4.9 billion in H1 Sun protection was pinpointed as a strong performance segment for the German giant's Nivea, Eucerin and Aquaphor brands

Upcoming event

CCE Safety Assessment Module 3, Toxicology 2

23 April 2024 | Virtual See all

You may also like

Skin Care

J&J to hold 9.5% stake in consumer health spinoff Kenvue following share exchange

The multinational launched the exchange offer in July in a bid to take its hands off the Kenvue reins
You need to be a subscriber to read this article.
Click here to find out more.
Sustainability

Top 50 beauty brands 2023: Which is the world’s biggest brand?

L’Oréal has retained its status as the world’s most valuable beauty brand on Brand Finance’s league table, but did its value rise or dive in 2023?
Body Care

Johnson & Johnson readies IPO for Kenvue consumer health business

The subsidiary could raise as much as $3.5 billion via the sale of 151,204,000 shares of its common stock
Regulatory

J&J's first quarter earnings plummet following $6.9 billion talc litigation charge

J&J originally proposed a $8.9bn settlement to resolve its ongoing talc litigation woes, and its subsidiary LTL Management has refiled for Chapter 11 bankruptcy
Regulatory

Johnson & Johnson proposes $8.9 billion for talc settlements

J&J subsidiary LTL Management has refiled for bankruptcy following Third Circuit rejection
Regulatory

Johnson & Johnson’s consumer health unit Kenvue files for IPO

The unit has filed to be listed as an independent company under the ticker symbol KVUE
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory

Year in review: 2022’s biggest beauty stories and headlines

These are the news stories that took the beauty world by storm this year, spanning celeb court cases, bankruptcy, resignations and moves in the metaverse
Subscribe now